Biomimetic Bone Marrow Monocyte Membrane‐Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction
Advanced Science · 2026-07 · 13 (41)
DOI: 10.1002/advs.75445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.04.2026. Verfasst von Jiaxin Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School…. Hauptthemen laut MEDLINE: Myocardial Infarction, Extracellular Vesicles, Monocytes, Biomimetics. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Sailing Program, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Myocardial infarction (MI) represents a major public health challenge. Extracellular vesicles (EVs) hold considerable promise as therapeutics for cardiovascular disorders. However, the targeted delivery of them to the heart has received relatively limited research. Acute MI is often accompanied by severe inflammation. After MI, numbers of monocytes/macrophages are rapidly mobilized from the circulation and accumulate within the ischemic myocardial tissue. This recruitment is driven by the inflammatory homing signals emanating from the injured cardiac region. In this work, we develop a biomimetic nanovesicle by fusing membranes isolated from bone marrow mononuclear cells (Mon) with extracellular vesicles derived from healthy human plasma (M‐hEV). This biomimetic delivery platform achieves site‐specific accumulation at damaged vascular endothelial cells and cardiomyocytes by leveraging two key molecular recognition mechanisms: the monocyte chemoattractant protein‐1 (MCP‐1)/C‐C chemokine receptor 2 (CCR2) and intercellular adhesion molecule‐1 (ICAM‐1)/CD11b axes. The results indicate that M‐hEV can inhibit apoptosis of vascular endothelial cells and cardiomyocytes, promote angiogenesis and regulate macrophage polarization at the cellular and animal levels. Furthermore, M‐hEV can home to the MI heart, reduce the infarct size, reduce the inflammation level, and improve cardiac function. This biomimetic system provides a novel approach to explore new targeted drugs for MI treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) and School of Life Science, Shanghai University, Nantong, China.
- Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Science, Joint International Research Laboratory of Biomaterials and Biotec…
- Cardiovascular Division of the Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Cardiology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Guoping Li, Jizong Jiang
Förderung
- National Natural Science Foundation of China
- Shanghai Sailing Program
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Song, J., Yang, H., Zhang, Q., Zhou, W., Wang, R., Xie, Y., Chatterjee, E., Li, G., Jiang, J., Zhou, Q., & Zhao, C. (2026). Biomimetic Bone Marrow Monocyte Membrane‐Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction. Advanced Science, 13(41). https://doi.org/10.1002/advs.75445
Vancouver
Song J, Yang H, Zhang Q, Zhou W, Wang R, Xie Y, et al. Biomimetic Bone Marrow Monocyte Membrane‐Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction. Advanced Science. 2026;13(41). doi:10.1002/advs.75445
BibTeX
@article{Song2026,
author = {Song, Jiaxin and Yang, Hao and Zhang, Qiqi and Zhou, Wenqin and Wang, Rui and Xie, Yuxing and Chatterjee, Emeli and Li, Guoping and Jiang, Jizong and Zhou, Qiulian and Zhao, Cuimei},
title = {Biomimetic Bone Marrow Monocyte Membrane‐Fused Extracellular Vesicles for Targeted Therapy of Myocardial Infarction},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {41},
doi = {10.1002/advs.75445}
}
EUVIMED